Vitreon America, Inc. (Vitreon) has been formed with the goal of disseminating,
organizing, and making available on a subscription basis, the entirety, portions,
and relevant elements of what is known as James A Duke's Phytochemical and Ethnobotanical
Prior to the 1940s most of pharmaceuticals consisted of plant-based products and
this turning point in the worldwide pharmaceutical industry coincides with a willingness
– even urgency – to look back upon plants in their natural essence as a basis for
The reasons for the pharmaceutical industry to look towards nature for medicinal
answers are numerous:
- Chemical formulations are expensive and uncertain: Even when side effects do not
prevent potential products from getting to the market, time to market is 8 years
on average. Once off-patent, the company can be sued for undisclosed or misrepresented
side effects for 5 to 12 years until the limits of liability run out -- unless new
liabilities are identified and then new clocks start on lawsuits.
- Engineered products to date have been difficult to make in a cost-efficient manner.
- Pharmaceutical sales today are 20% proprietary and 80% generic as the pipelines
continue to dry up.
- Botanicals are the best options for the “non-chemical” actives.
Vitreon America Management Team
Chief Executive Officer
Mr. Sandberg has an international background within banking and pharmaceuticals.
Within banking, Mr. Sandberg has had a focus on business strategy, asset management
and financial analysis, including leadership roles in Landkreditt Bank as Bank Manager
and Storebrand ASA as an Asset Manager. Within pharmaceuticals, Mr. Sandberg has
had various key roles including Scandinavian Innovation Manager for Eli Lilly, and
Nycomed Sales Manager of the Year. He is widely recognized for his coaching, mentoring
and training successes.
J. Randall Hoggle
(RPh, DPh, MBA)
Chairman of Board
Dr. Hoggle has over 30 years of leadership experience in the pharmaceutical and
medical device industries. He has worked in all aspects of the pharmaceutical industry
and his commercial experience includes business development, business turnaround,
strategic partnership development, product development, registration and commercialization.
Dr. Hoggle currently serves as Chairman of HP Holdings, LLC which consists of six
companies in a combination of healthcare products, medical care and information
system infrastructure expertise, healthcare product systems and infrastructure services
and Emergency Preparedness and Response strategic planning and deployment systems,
headquartered in Gaithersburg, Maryland and is Chairman of Intelaform, Inc. and
Chairman/President of Domaine Healthcare, Inc. headquartered in Rockville, Maryland.